These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 39201794)
1. An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis. Dolcetti E; Buttari F; Bruno A; Azzolini F; Gilio L; Borrelli A; Di Caprio V; Lauritano G; Galifi G; Gambardella S; Ferese R; Giardina E; Rovella V; Furlan R; Finardi A; Musella A; Balletta S; Mandolesi G; Centonze D; Stampanoni Bassi M Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201794 [TBL] [Abstract][Full Text] [Related]
2. Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis. Mohammadi SM; Shirvani Farsani Z; Dosti R; Sahraian MA; Behmanesh M Neuropeptides; 2016 Dec; 60():45-50. PubMed ID: 27559040 [TBL] [Abstract][Full Text] [Related]
3. Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. Rossi S; Studer V; Moscatelli A; Motta C; Coghe G; Fenu G; Caillier S; Buttari F; Mori F; Barbieri F; Castelli M; De Chiara V; Monteleone F; Mancino R; Bernardi G; Baranzini SE; Marrosu MG; Oksenberg JR; Centonze D PLoS One; 2013; 8(6):e67357. PubMed ID: 23840674 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis. Tavakolpour S Mult Scler Relat Disord; 2016 Jul; 8():66-73. PubMed ID: 27456877 [TBL] [Abstract][Full Text] [Related]
7. Interleukin 7 Receptor Alpha Gene Variants Are Correlated with Gene Expression in Patients with Relapsing-remitting Multiple Sclerosis. Sayad A; Omrani MD; Solgi G; Noroozi R; Arsang-Jang S; Inoko H; Taheri M Iran J Allergy Asthma Immunol; 2017 Aug; 16(4):338-346. PubMed ID: 28865414 [TBL] [Abstract][Full Text] [Related]
8. Impact of IL-21 Gene Polymorphisms (rs2055979) and the Levels of Serum IL-21 on the Risk of Multiple Sclerosis. Ali Abdulla A; Abdulaali Abed T; Razzaq Abdul-Ameer W Arch Razi Inst; 2022 Feb; 77(1):81-86. PubMed ID: 35891764 [TBL] [Abstract][Full Text] [Related]
9. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course. Stampanoni Bassi M; Iezzi E; Landi D; Monteleone F; Gilio L; Simonelli I; Musella A; Mandolesi G; De Vito F; Furlan R; Finardi A; Marfia GA; Centonze D; Buttari F J Neurol; 2018 Nov; 265(11):2540-2547. PubMed ID: 30167879 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in proinflammatory cytokines genes and susceptibility to Multiple Sclerosis. Bakr NM; Hashim NA; El-Baz HAE; Khalaf EM; Elharoun AS Mult Scler Relat Disord; 2021 Jan; 47():102654. PubMed ID: 33302229 [TBL] [Abstract][Full Text] [Related]
11. Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran. Asgharzadeh M; Jigheh ZA; Kafil HS; Farhoudi M; Oskouei DS; Khaki-Khatibi F; Fadaee M; Vegari A; Asgharzadeh V; Najafi-Ghalelou N; Poor BM; Rashedi J Endocr Metab Immune Disord Drug Targets; 2020; 20(7):1110-1116. PubMed ID: 32148206 [TBL] [Abstract][Full Text] [Related]
12. A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Stampanoni Bassi M; Buttari F; Simonelli I; Gilio L; Furlan R; Finardi A; Marfia GA; Visconti A; Paolillo A; Storto M; Gambardella S; Ferese R; Salvetti M; Uccelli A; Matarese G; Centonze D; De Vito F Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33007809 [TBL] [Abstract][Full Text] [Related]
14. Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis. Soares JL; Oliveira EM; Pontillo A Mult Scler Relat Disord; 2019 Apr; 29():26-34. PubMed ID: 30658261 [TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis. Schrijver HM; van As J; Crusius JB; Dijkstra CD; Uitdehaag BM Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358 [TBL] [Abstract][Full Text] [Related]
16. Association between interleukin-32 polymorphism and multiple sclerosis. Morsaljahan Z; Rafiei A; Valadan R; Abedini M; Pakseresht M; Khajavi R J Neurol Sci; 2017 Aug; 379():144-150. PubMed ID: 28716229 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations. Suppiah V; Goris A; Alloza I; Heggarty S; Dubois B; Carton H; Antigüedad A; Mendibe M; McDonnell G; Droogan A; Hawkins S; Graham C; Vandenbroeck K Int J Immunogenet; 2005 Dec; 32(6):383-8. PubMed ID: 16313303 [TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-17F (rs763780) single nucleotide polymorphism with multiple sclerosis and optic neuritis. Salah S; Sadeq YI; Mosaad YM; Elmenshawi IEH; Tawhid ZME Sci Rep; 2024 Jun; 14(1):13643. PubMed ID: 38871733 [TBL] [Abstract][Full Text] [Related]
19. Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients. D'Angelo C; Reale M; Costantini E; Di Nicola M; Porfilio I; de Andrés C; Fernández-Paredes L; Sánchez-Ramón S; Pasquali L Front Immunol; 2018; 9():1240. PubMed ID: 29915590 [TBL] [Abstract][Full Text] [Related]
20. IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. Shokrgozar MA; Sarial S; Amirzargar A; Shokri F; Rezaei N; Arjang Z; Radfar J; Yousefi-Behzadi M; Ali Sahraian M; Lotfi J J Clin Immunol; 2009 Nov; 29(6):747-51. PubMed ID: 19543959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]